Li Shi-jun, Sun Ning-ling
Department of Cardiology, People's Hospital, Peking University, Beijing 100044, China.
Acta Pharmacol Sin. 2005 Mar;26(3):323-8. doi: 10.1111/j.1745-7254.2005.00049.x.
To determine whether Ca2+/calcineurin mediated the inhibitory effects of nitric oxide /cGMP-dependent protein kinase (NO/PKG) on the proliferation of vascular smooth muscle cells (VSMC).
Proliferation and viability of primary VSMC from rat aorta were measured using [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (MTT) assay and acridine orange and ethidium bromide staining, respectively. Cytosolic Ca2+ was determined by Fluo-3/AM. Calcineurin protein and its activity were assayed using immunoblotting and free inorganic phosphate analysis, respectively.
(+/-)-S-nitroso-N-acetyl-penicillamine (SNAP) and Sp-8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphorothioate (Sp-8-pCPT-cGMPS) decreased phenylephrine (PE)-induced proliferation of VSMC by 27.3% and 36.6%, respectively, but Rp-8-[(4-chlorophenyl)thio]-guanosine-3',5'-cyclic monophosphorothioate (Rp-8-pCPT-cGMPS) increased PE-induced proliferation of VSMC. SNAP, Sp-8-pCPT-cGMPS, and Rp-8-pCPT-cGMPS did not affect the viability of VSMC. Calcineurin protein was decreased by 63.1% and its activity was decreased by 59.7% in smooth muscle cells (SMC) pretreated with verapamil (Ver) and then stimulated by PE. In SMC pretreated with Ver, the absorbance of cells stimulated by PE decreased by 22.0% and was further inhibited by the additional treatment of SNAP and Sp-8-pCPT-cGMPS. In SMC pretreated with cyclosporin A (CsA), the absorbance of cells stimulated by PE decreased by 36.7%, but could not be further altered by the additional treatment of SNAP, Sp-8-pCPT-cGMPS, and Rp-8-pCPT-cGMPS. In addition, Ver inhibited PE-induced intracellular Ca2+ variations, which could be further inhibited by SNAP and Sp-8-pCPT-cGMPS, but not by Rp-8-pCPT-cGMPS. Moreover, the increase in calcineurin activity induced by PE was inhibited by SNAP and Sp-8-pCPT-cGMPS, but was promoted by Rp-8-pCPT-cGMPS.
NO/PKG regulates calcineurin activity via the modulation of intracellular Ca2+ concentration, and thus partially inhibits the proliferation of VSMC without affecting their viability.
确定Ca2+/钙调神经磷酸酶是否介导一氧化氮/环磷酸鸟苷依赖性蛋白激酶(NO/PKG)对血管平滑肌细胞(VSMC)增殖的抑制作用。
分别采用[3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐](MTT)法和吖啶橙与溴化乙锭染色法检测大鼠主动脉原代VSMC的增殖和活力。采用Fluo-3/AM测定细胞内Ca2+浓度。分别用免疫印迹法和游离无机磷酸盐分析法检测钙调神经磷酸酶蛋白及其活性。
(±)-S-亚硝基-N-乙酰青霉胺(SNAP)和Sp-8-(4-氯苯硫基)-鸟苷-3',5'-环一磷酸硫代酯(Sp-8-pCPT-cGMPS)分别使去氧肾上腺素(PE)诱导的VSMC增殖降低27.3%和36.6%,但Rp-8-[(4-氯苯基)硫基]-鸟苷-3',5'-环一磷酸硫代酯(Rp-8-pCPT-cGMPS)使PE诱导的VSMC增殖增加。SNAP、Sp-8-pCPT-cGMPS和Rp-8-pCPT-cGMPS均不影响VSMC活力。用维拉帕米(Ver)预处理后再用PE刺激的平滑肌细胞(SMC)中,钙调神经磷酸酶蛋白降低63.1%,其活性降低59.7%。在用Ver预处理的SMC中,PE刺激的细胞吸光度降低22.0%,并被SNAP和Sp-8-pCPT-cGMPS的额外处理进一步抑制。在用环孢素A(CsA)预处理的SMC中,PE刺激的细胞吸光度降低36.7%,但SNAP、Sp-8-pCPT-cGMPS和Rp-8-pCPT-cGMPS的额外处理不能使其进一步改变。此外,Ver抑制PE诱导的细胞内Ca2+变化,SNAP和Sp-8-pCPT-cGMPS可进一步抑制,但Rp-8-pCPT-cGMPS不能。而且,PE诱导的钙调神经磷酸酶活性增加被SNAP和Sp-8-pCPT-cGMPS抑制,但被Rp-8-pCPT-cGMPS促进。
NO/PKG通过调节细胞内Ca2+浓度来调节钙调神经磷酸酶活性,从而部分抑制VSMC增殖而不影响其活力。